SetLance is a biotech company focusing its activity on the development of peptide-based drugs. It was founded in 2009 by Luisa Bracci, Chiara Falciani and Alessandro Pini, researchers at the University of Siena, Italy.
SetLance has its registered offices at Toscana Life Sciences campus in Siena.
The company aims at the development of novel peptide-based drug candidates for the treatment of severe human diseases – with a special focus on bacterial infections and cancer.
Setlance srl. Via Fiorentina 1, 53100 Siena. Italy.